Recurrent and new hepatitis C virus infection after liver transplantation

Hepatology

Volumn 29, Issue 4, 1999, Pages 1220-1226

  Evermart, James E ^a,f   Wei, Yuling ^b   Eng, Heather ^b   Charlton, Michael R ^c   Persing, David H ^c   Wiesner, Russell H ^c   Germer, Jeffrey J ^c   Lake, John R ^d   Zetterman, Rowen K ^e   Hoofnagle, Jay H ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^f MSC 6600 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; IMMUNOBLOTTING; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SEROLOGY; VIRUS LOAD; VIRUS TYPING;

EID: 0032924021     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290412     Document Type: Article

References (25)

1. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. Clin Transplant 1996;15-29.
2. Chazouilleres O, Wright TL. Hepatitis C and liver transplantation. J Gastroenterol Hepatol 1995;10:471-480.
3. Araya V, Rakela J, Wright T. Hepatitis C after orthotopic liver transplantation. Gastroenterology 1997;112:575-582.
4. Collier J, Heathcote J. Hepatitis C viral infection in the immunosuppressed patient. HEPATOLOGY 1998;27:2-6.
5. Pereira BJ, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995;345:484-487.
6. Wreghitt TG, Gray JJ, Allain JP, Poulain J, Garson JA, Deaville R, Maple C, et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994;20:768-772.
7. Hsu HH, Wright TL, Tsao SC, Combs C, Donets M, Feinstone SM, Greenberg HB. Antibody response to hepatitis C virus infection after liver transplantation. AmJ Gastroenterol 1994;89:1169-1174.
8. Wei YL, Detre KM, Everhart JE. The NIDDK liver transplantation database. Liver Transplant Surg 1997;3:10-22.
9. Shindo M, DiBisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-704.
10. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996;34:2259-2266.
11. SAS Institiute Inc. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute Inc., 1989.
12. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
13. Gart JJ. Point and interval estimation of the common odds ratio in the combination of 2x2 tables with fixed marginals. Biometrika 1970;57:471-475.
14. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
15. Barcena R, Del Campo S, Sanroman AL, Nuno J, Zelaya R, Honrubia A, Vicente E, et al. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplant Proc 1997;29:515-516.
16. Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998;42:570-575.
17. Schmidt WN, Wu P, Cederna J, Mitros FA, LaBrecque DR, Stapleton JT. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 1997;176:27-33.
18. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997;127:875-381.
19. Weiland O. Can HCV infection be cleared? Lancet 1998;352:669-670.
20. Feucht HH, Zollner B, Polywka S, Laufs R. Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol 1995;33:620-624.
21. Vargas HE, Wang LF, Laskus T, Poutous A, Lee R, Demetris A, Dodson F, et al. Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. J Infect Dis 1997;175:448-450.
22. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
23. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125:634-639.
24. Terrault NA, Wright TL. Hepatitis C virus in the setting of transplantation. Semin Liver Dis 1995;15:92-100.
25. Feray C, Gigou M, Samuel D, Ducot B, Maisonneuve P, Reynes M, Bismuth A, et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998;128:810-816.